Differences in Ulcer Location in Diabetic Foot Syndrome

Česká verzia

Authors: P. Piťhová; H. Pátková; I. Galandáková; L. Doležalová; M. Kvapil
Authors place of work: Interní klinika 2. lékařské fakulty UK a FN Motol, Praha, přednosta prof. MUDr. Milan Kvapil, CSc., MBA
Published in the journal: Vnitř Lék 2007; 53(12): 1278-1285
Category: Original Contributions

Summary

The foot ulcerations are among the most debilitating complications in diabetic patients. The main risk factors leading to the ulcer development are diabetic neuropathy (sensoric, autonomic), limb ischemia (angiopathy), limited joint mobility and teh plantar pressure; the infection plays a role in difficulty of ulcer healing. The aim of our study was to assess the possible differences in location of diabetic ulcers with regard to their origin. In 502 patients during 5 year interval 835 new diabetic ulcers were diagnosed.

Methods:
Ulcers were divided into 3 groups according to their origin: neuropathic, neuroischemic and ischemic.

Results:
In the neuropathic group most ulcers were found in the plantar surface of toes (40.4 %) and in the plantar metatarsal heads region (39.1 %); in contrast, the ischemic group had the most frequent location in the toe tips (63.6 %), while the neuroischemic group had most ulcers distributed in both plantar surface and tips of the toes (51.8 %). The ulcer distribution was statistically significant different in all groups and depended on the etiology of ulcers (p < 0.0001; Fisher’s exact test, modification Monte Carlo). Totally more than 75 % of all ulcer were located in the toe and forefoot area. The patients in the neuroischaemic group had more often revascularisation procedures. The patients in ischaemic group were more often after high amputation. These patients had always less microvascular diabetic complication (all p < 0.01; ANOVA χ²).

Conclusion:
The location of diabetic foot ulcers differs significantly according to their cause. In addition more than 75 % of all ulcerations were localisated in toes and forefoot area. This fact could change focus of the preventive strategy in the diabetic foot.

Key words:
the diabetic foot syndrom – diabetic neuropathy – diabetic angiopathy – diabetic footwear – prevention of diabetic ulceration

Zdroje

1. Abbot CA, Garrow AP, Carrington AL et al. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the U.K. The North-West foot care diabetes study. Diabetes Care 2005; 28: 1869-1875.

2. Apelqvist J, Castenfors J, Larsson J et al. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers. Diabetic Medicine 1989, 6: 526-530.

3. Boulton AJM. The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004; 47: 1343-1353.

4. Boulton AJM, Hardisty CA, Betts RP et al. Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care 1983; 6: 26-33.

5. Boyko EJ, Ahroni JH, Cohen V et al. Prediction of diabetic foot ulcer occurrence using commonly available clinical information. The Seattle diabetic foot study. Diabetes Care 2006; 29: 1202-1207.

6. Cavanagh PR, Ulbrecht JS. Biomechanics of the foot in diabetes mellitus. J Am Podiatr Med Assoc 1998; 88: 285-289.

7. Ctercteko GC, Dhanendran M, Hutton WC et al. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981; 68: 608-614.

8. Edmonts ME, Blundell MP, Morris ME et al. Improved survival of the diabetic foot: the role of a specialised foot clinic. Q J Med 1986; 60: 763-771.

9. Ince P, Game FL, Jeffcoate WJ. Rate of healing of neuropathic ulcers of the foot in diabetes and its relationship to ulcer duration and ulcer area. Diabetes Care 2007; 30: 660-663.

10. Jirkovská A (ed). Syndrom diabetické nohy - Mezinárodní konsenzus vypracovaný Mezinárodní pracovní skupinou pro syndrom diabetické nohy. Praha: Galén 2000.

11. Oliva I. Netradiční způsob hodnocení výsledků perkutánní tepenné angioplastiky na dolních končetinách. Vnitř Lék 1997; 43: 425-427.

12. Papanas N, Gries A, Maltezos E et al. The steel ball-bearing test: a new test in the diabetic foot. Diabetologia 2006; 49: 739-743.

13. Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25.

14. Ragnarson Tennvall G, Apelqvist J. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations. Diabetologia 2001; 44: 2077-2087.

15. Reiber GE. Epidemiology and health care costs of diabetes foot problems. The diabetic foot. Totowa: Human Press 2002; 35-38.

16. Rušavý Z. Diabetická noha. Praha: Galén 1998.

17. Schie CHM. A Review of the Biomechanics of the Diabetic Foot. Int J Low Extrem Wounds 2005; 4: 160-170.

18. Tošenovský P, Edmonds ME. Moderní léčba syndromu diabetické nohy. Praha: Galén 2004.

19. Tošenovský P, Zálešák B, Janoušek L et al. Pedální bypass v léčbě ischemie diabetické nohy - střednědobé výsledky. Vnitř Lék 2005; 51: 163-166.

20. Williams R, Airey M. The size of the problem: epidemilogical and economic aspects of foot problem in diabetes. The Foot in Diabetes. 3rd ed. Chichester: Willey 2000; 3-17.

21. Záhumenský E. Infekce a syndrom diabetické nohy v terénní praxi. Vnitř Lék 2005; 52: 411-416.

22. Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot. Diabetes Care 2004; 27: 942-946.